Sponsor Pipeline

Gritgen Therapeutics Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
1
Recruiting
1
Phase 3
1
Disease Areas
Active Trials by Phase
Phase 3
1
Phase 1/2
1
Early Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06833983 To Evaluate the Clinical Study of GS1191-0445 Injection in the Treatment of Hemophilia A Hemophilia A Recruiting
Phase 1/2
NCT07548411 To Evaluate the Safety and Efficacy of GS1191-0445 Injection in the Treatment of Severe… Severe Hemophilia A Active, Not Recruiting
Early Phase 1
NCT07318909 To Evaluate the Safety and Efficacy of GS1168 Injection in Adult Phenylketonuria Phenylketonuria (PKU) Not Yet Recruiting
Disease Areas
Hemophilia (2)
Get alerts when Gritgen Therapeutics Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free